GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai Fosun Pharmaceutical Group Co 600196.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

23.11

-1.99%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

10 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 1Strong buy
  • 6Buy
  • 3Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 38.05

Low
30.30
Average
38.05
Median
38.38
High
44.52

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueCN¥41.81bnCN¥43.74bnCN¥47.44bn
Revenue, highestCN¥42.06bnCN¥45.50bnCN¥49.59bn
Revenue, lowestCN¥41.35bnCN¥41.78bnCN¥45.28bn
Earnings per share1.101.631.76
Earnings per share, highest1.101.801.93
Earnings per share, lowest1.101.371.47
Analysts366

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast0.350.360.330.290.300.280.300.26
Reported0.360.320.330.320.310.350.290.29
Difference+2.9%-11.1%+1.5%+9.3%+2.3%+26.0%-2.7%+12.6%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

2 / 10

Revenue growth 12.7% a year over 10 years. Return on equity 6.9%.

Model fair value

25.29

From earnings 25.29, from revenue 25.47.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.